Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5208468
Max Phase: Preclinical
Molecular Formula: C20H16F3N3O4S
Molecular Weight: 451.43
Associated Items:
ID: ALA5208468
Max Phase: Preclinical
Molecular Formula: C20H16F3N3O4S
Molecular Weight: 451.43
Associated Items:
Canonical SMILES: O=c1nc(N2CC[C@H](c3ccccc3)[C@@H](O)C2)sc2c([N+](=O)[O-])cc(C(F)(F)F)cc12
Standard InChI: InChI=1S/C20H16F3N3O4S/c21-20(22,23)12-8-14-17(15(9-12)26(29)30)31-19(24-18(14)28)25-7-6-13(16(27)10-25)11-4-2-1-3-5-11/h1-5,8-9,13,16,27H,6-7,10H2/t13-,16+/m1/s1
Standard InChI Key: WMNAOBPVNOZVHP-CJNGLKHVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 451.43 | Molecular Weight (Monoisotopic): 451.0814 | AlogP: 3.94 | #Rotatable Bonds: 3 |
Polar Surface Area: 96.57 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.84 | CX LogD: 3.84 |
Aromatic Rings: 3 | Heavy Atoms: 31 | QED Weighted: 0.48 | Np Likeness Score: -1.21 |
1. Schieferdecker S, Bernal FA, Wojtas KP, Keiff F, Li Y, Dahse HM, Kloss F.. (2022) Development of Predictive Classification Models for Whole Cell Antimycobacterial Activity of Benzothiazinones., 65 (9.0): [PMID:35502994] [10.1021/acs.jmedchem.2c00098] |
Source(1):